Ki67 as a Prognostic and Predictive Biomarker in HR-Positive/HER2-Negative Early Breast Cancer
This 60-minute interactive webinar will feature the expertise of a pathologist and an oncologist highlighting important and practice-changing developments related to the use of Ki67 biomarker testing in patients with HR-positive/HER2-negative early breast cancer, such as new clinical data with immediate implications for patient care. Case-based, and with expert perspectives and recommendations, this webinar addresses key educational gaps and controversies related to optimal Ki67 biomarker testing methods, including challenges with standardization, interpreting findings, and potential therapeutic implications for patients with HR-positive/HER2-negative early breast cancer to optimize clinical outcomes.
Topics covered will include:
-
Analytical validity of Ki67 as a diagnostic assay, application of results in clinical practice, and relevance to therapy
-
Current and emerging therapies for HR-positive/HER2-negative early-stage breast cancer
-
Current standardized methodologies for Ki67 quantification
-
Optimizing workflows and communications with the multidisciplinary team
The activity offers 1.0 CME/CMLE credit.
The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.
Faculty/Authors
Sunil S. Badve, MD, FRCPath
Vice Chair, Pathology Cancer Programs, Department of Pathology and Laboratory Medicine
Emory University School of Medicine
Atlanta, GA
Manali Bhave, MD
Assistant Professor, Department of Hematology and Medical Oncology
Emory University School of Medicine
Atlanta, GA
Physician's Competency: Patient care, Medical knowledge, Interpersonal and Communication Skills, Professionalism
CME/CMLE Credit: 1.0
Estimated Completion Time: 1.0 hour
Format: Online educational activity
Credit Designation Statement
The ASCP designates this internet activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
ASCP designates this internet activity for a maximum of 1.0 CMLE credit. This activity meets CMP and state re-licensure requirements for laboratory personnel.
For questions regarding CME credit, please contact ASCP Customer Service at 1-800-267-2727, during normal business hours: Monday through Friday, 8 a.m. to 6 p.m. Eastern Time
Method of Participation
To complete the activity and receive credit, the participant must complete the online course. CME certificates will be provided online.
Provided by the American Society for Clinical Pathology in partnership with Clinical Care Options, LLC
This activity is supported by an educational grant from Lilly.
Instructions
To claim CME/CMLE credit for the exercise, do the following:
- Review the Technical Considerations.
- Click Go to Content and click the first module of the course.
- Complete the Demographic Survey.
- Review the Educational Activity.
- Submit the Post-Activity Survey.
- Submit the course Evaluation.
- Enter the maximum number of credits offered and click Claim CME/CMLE to register credit.
Faculty Disclosures Technical Considerations Release Dates:
3/17/2022 Review Date:Expiration Date: 3/17/2025